» Articles » PMID: 24367216

Serum Anti-modified Citrullinated Vimentin Antibody Concentration is Associated with Liver Fibrosis in Patients with Chronic Hepatitis

Overview
Journal Hepat Med
Publisher Dove Medical Press
Specialty Gastroenterology
Date 2013 Dec 25
PMID 24367216
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Aims: The hepatic stellate cell, which plays a pivotal role in hepatic fibrosis, contains the filament vimentin which is known to undergo protein citrullination and become immunogenic. The aims of this study were to find out if anti-modified citrullinated vimentin (anti-MCV) antibodies are produced in patients with chronic hepatitis and if such production is associated with liver fibrosis.

Methods: Sera and liver biopsy specimens were collected from 100 patients with chronic hepatitis. Sera were also collected from 100 healthy controls. The liver biopsies were graded according to the Metavir fibrosis scores. The serum concentrations of anti-MCV antibody were measured in both patients and controls by ELISA using commercially available kits.

Results: The mean serum concentration of anti-MCV antibody in patients with chronic hepatitis (54.90 ± 6.09 U/mL) was significantly higher (P = 0.001) than that of controls (17.38 ± 0.56 U/mL). Furthermore, serum anti-MCV antibody titer was able to separate patients with no fibrosis from those with moderate or severe fibrosis or cirrhosis. Using receiver operating characteristic curves, a serum concentration of anti-MCV antibody of 8.82 U/mL was able to diagnose cirrhosis with 60% specificity and 60% sensitivity.

Conclusion: We concluded that serum anti-MCV antibody concentration may be a sensitive noninvasive marker for liver cirrhosis that needs to be investigated further.

Citing Articles

Expression of Peptidyl Arginine Deiminase 2 Is Closely Associated with Recurrence in Patients with Hepatocellular Carcinoma.

Uhm S, Cho Y, Choe J, Park J, Kim M, Han W Diagnostics (Basel). 2023; 13(4).

PMID: 36832148 PMC: 9955443. DOI: 10.3390/diagnostics13040659.


Possible Role of Extracellular Vesicles in Hepatotoxicity of Acetaminophen.

Srajer Gajdosik M, Kovac Peic A, Begic M, Grbcic P, Brilliant K, Hixson D Int J Mol Sci. 2022; 23(16).

PMID: 36012131 PMC: 9408656. DOI: 10.3390/ijms23168870.


Accumulation of citrullinated glial fibrillary acidic protein in a mouse model of bile duct ligation-induced hepatic fibrosis.

Kim S, Park J, Kim M, Jang B, Jeon Y, Kim H PLoS One. 2018; 13(8):e0201744.

PMID: 30071078 PMC: 6072123. DOI: 10.1371/journal.pone.0201744.


In wound repair vimentin mediates the transition of mesenchymal leader cells to a myofibroblast phenotype.

Walker J, Bleaken B, Romisher A, Alnwibit A, Menko A Mol Biol Cell. 2018; 29(13):1555-1570.

PMID: 29718762 PMC: 6080657. DOI: 10.1091/mbc.E17-06-0364.


Circulating levels of citrullinated and MMP-degraded vimentin (VICM) in liver fibrosis related pathology.

Vassiliadis E, Oliveira C, Alvares-da-Silva M, Zhang C, Carrilho F, Stefano J Am J Transl Res. 2012; 4(4):403-14.

PMID: 23145208 PMC: 3493028.

References
1.
Mastronardi F, Wood D, Mei J, Raijmakers R, Tseveleki V, Dosch H . Increased citrullination of histone H3 in multiple sclerosis brain and animal models of demyelination: a role for tumor necrosis factor-induced peptidylarginine deiminase 4 translocation. J Neurosci. 2006; 26(44):11387-96. PMC: 6674531. DOI: 10.1523/JNEUROSCI.3349-06.2006. View

2.
Wright P, Bolling L, Calvert M, Sarmento O, Berkeley E, Shea M . ePAD, an oocyte and early embryo-abundant peptidylarginine deiminase-like protein that localizes to egg cytoplasmic sheets. Dev Biol. 2003; 256(1):73-88. DOI: 10.1016/s0012-1606(02)00126-4. View

3.
Giannini E, Risso D, Botta F, Chiarbonello B, Fasoli A, Malfatti F . Validity and clinical utility of the aspartate aminotransferase-alanine aminotransferase ratio in assessing disease severity and prognosis in patients with hepatitis C virus-related chronic liver disease. Arch Intern Med. 2003; 163(2):218-24. DOI: 10.1001/archinte.163.2.218. View

4.
Bedossa P, Poynard T . An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology. 1996; 24(2):289-93. DOI: 10.1002/hep.510240201. View

5.
van Venrooij W, Hazes J, Visser H . Anticitrullinated protein/peptide antibody and its role in the diagnosis and prognosis of early rheumatoid arthritis. Neth J Med. 2003; 60(10):383-8. View